The Ahi Evran Medical Journal is committed to the highest standards of research and publication ethics, and does not allow any form of plagiarism. All submitted manuscripts are screened with plagiarism software at least two times during the evaluation period to detect any overlapping and similar text. High similarity results may lead rejection of a manuscript even after acceptance.

The Publisher and the Editorial Board of the Ahi Evran Medical Journal adhere to the guidelines of the International Committee of Medical Journal Editors (ICMJE), Committee on Publication Ethics (COPE), World Association of Medical Editors (WAME), Council of Science Editors (CSE), European Association of Science Editors (EASE), the US National Library of Medicine (NLM), the World Medical Association (WMA), and National Information Standards Organization (NISO). The journal is in conformity with the Principles of Transparency and Best Practice in Scholarly Publishing (doaj.org/bestpractice).

As journal's policy, an approval of research protocols by an ethics committee in accordance with international agreements “WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects (last updated: October 2013, Fortaleza, Brazil)” , "Guide for the care and use of laboratory animals (8th edition, 2011)" and/or “International Guiding Principles for Biomedical Research Involving Animals (2012)” is required for all research studies. If the submitted manuscript does not include ethics committee approval, it will not be processed for evaluation.

For articles concerning experimental research on humans, a statement should be included that shows informed consent of patients and volunteers was obtained following a detailed explanation of the procedures that they may undergo. The journal may request a copy of the Ethics Committee Approval from authors. Informed consent must also be obtained for case reports.

Authors are strongly encouraged to uphold the highest ethical standards and avoid engaging in any behaviors that constitute misconduct, as exemplified below:

Citation manipulation: This involves manipulating the number of citations received by an author, journal, or publication through various tactics, such as excessive self-citation, over-referencing articles from the same journal, or including honorary citations or citation stacking.

Self-plagiarism (text-recycling): This practice entails reusing sections or sentences from an author's previous works without proper citation, which is considered a form of plagiarism since it utilizes someone else's work (in this case, the author's own) without appropriate attribution.

Salami slicing: This unethical practice involves splitting the same research data into multiple articles, essentially reporting the same hypotheses, study population, and methods across different papers.

Data Fabrication: This misconduct involves adding false data that was not actually collected during research or experiments, presenting deceptive information as genuine data.

Data Manipulation/Falsification: This refers to the unethical practice of altering research data with the intent of creating a false impression. Examples include manipulating images, omitting outliers or inconvenient results, altering data points, and other forms of manipulation to present misleading information as legitimate data.

In cases of alleged or suspected research misconduct, such as plagiarism, citation manipulation, or data falsification/fabrication, the Editorial Board will adhere to the appropriate COPE (Committee on Publication Ethics) guidelines to ensure that these allegations or suspicions are handled fairly, transparently, and consistently.